GlaxoSmithKline (GSK) Financial Analysis & Valuation | Quarter Chart

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Tota... more
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of va... more

Company facts

Reported company information and share structure.

Company Share structure
Market Cap$103.66BExchangeNYSE
SectorHealthcareIndustryDrug Manufacturers - General
CountryGBCEOLuke Victor Miels
IPO Date1980-03-28CAGR8.35%
Employees66,841Websitewww.gsk.com
Div. Yield2.46%Payout Ratio45%
Buy Back Yield0.9%Total Yield3.36%
GSK chart loading...

Key metrics

Reported fundamentals and market-derived technical indicators.

Fundamentals Technicals
Enterprise Value$104.87BP/E Ratio11.18
Forward P/E10.1PEG Ratio1.64
P/S Ratio3.31P/B Ratio6.15
P/CF Ratio14.51P/FCF Ratio21.66
EPS$4.63EPS Growth 1Y122.22%
EPS Growth 3Y48.67%EPS Growth 5Y28.24%
Revenue Growth 1Y3.97%Gross Margin0.73%
Operating Margin0.22%Profit Margin0.18%
ROE0.36%ROA0.09%
ROCE0.18%Current Ratio0.79
Quick Ratio0.52Cash Ratio0.15
Debt/Equity1.07Interest Coverage10.37
Altman Z Score1.66Piotroski Score7

View GlaxoSmithKline financial charts →

GlaxoSmithKline (GSK) valuation & financials

GlaxoSmithKline (GSK) has a market capitalization of $103.66B and trades at a price-to-earnings ratio of 11.2. It operates in the Healthcare sector (Drug Manufacturers - General).

GlaxoSmithKline's revenue grew +4.0% over the last year.

GlaxoSmithKline's next earnings report is scheduled for July 28, 2026 before market open; analysts estimate EPS of $1.27.

📈 Analysts estimate GSK EPS of $1.27 for the upcoming quarter. See GlaxoSmithKline revenue & EPS analyst forecasts for the next four quarters with Quarter Chart Premium.

GlaxoSmithKline (GSK) — frequently asked questions

When does GlaxoSmithKline (GSK) report earnings next?

GlaxoSmithKline is expected to report earnings on July 28, 2026 before market open. Analysts estimate EPS of $1.27.

What is GlaxoSmithKline's market cap?

GlaxoSmithKline (GSK) has a market capitalization of $103.66B.

What is GSK's P/E ratio?

GlaxoSmithKline trades at a price-to-earnings ratio of 11.2, with trailing twelve-month EPS of $4.63.

How fast is GlaxoSmithKline growing?

GlaxoSmithKline's revenue grew +4.0% over the last year.

Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Roche (ROG.SW) · Merck (MRK)

GlaxoSmithKline revenue & earnings charts →